Shares of eyecare company Bausch + Lomb (NYSE:BLCO) fell 10.6% in the afternoon session after the company announced the voluntary recall of intraocular lenses on its enVista platform. The recall ...

Bausch + Lomb has recalled lenses used during cataract surgery due to complications when the lenses are used, according to an announcement from the Canada-based eyecare company posted on the U.S ...

LAVAL, QC / ACCESS Newswire / April 14, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) (the "Company" or "Bausch Health") announces today that its board of directors (the "Board") has ...

Please provide your email address to receive an email when new articles are posted on . Bausch + Lomb has received reports of toxic anterior segment syndrome in patients with enVista IOLs.

Fitch Ratings upgraded its credit grade on both Bausch + Lomb Corp. and its parent company Bausch Health Cos., but said the eye care unit’s ratings will continue to be under pressure unless the ...

Bausch + Lomb has announced a voluntary recall of intraocular lenses on its enVista platform due to the potential for an acute postoperative inflammatory reaction. All lots of the following ...

Bausch + Lomb (NYSE:BLCO) on Thursday announced a voluntary recall of several brands of intraocular lenses marketed under its enVista brand in response to reports of adverse events. Accordingly ...

The eye health company Bausch + Lomb announced on Monday that it is recalling several of its intraocular lenses due to safety concerns. The company said it was recalling several of its enVista ...

Bausch + Lomb is recalling intraocular lenses (IOLs) on its enVista platform. This action was taken after the company received reports of complications, the cause of which could not immediately be ...

Recall issued in response to reports of toxic anterior segment syndrome. HealthDay News — Bausch + Lomb has announced a voluntary recall of intraocular lenses on its enVista platform due to the ...